This rarity is mirrored in the scarcity of epidemiological and mechanistic data; there is a notable lack of cohort studies quantifying HCC risk in HHT populations, and the potential involvement of ENG/ACVRL1 pathways in hepatocarcinogenesis is not yet defined. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.